Hong Kong, China

Aifang Cheng

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Aifang Cheng: Innovator in Neurodegenerative Disease Treatments and HIV Research

Introduction

Aifang Cheng is a prominent inventor based in Hong Kong, CN, known for his groundbreaking contributions to medical science through his innovative patents. With a total of two registered patents, Cheng focuses on therapeutic agents aimed at combating neurodegenerative diseases and HIV.

Latest Patents

Aifang Cheng's latest patents include significant advancements in treating various neurodegenerative conditions. The first patent is titled "Compounds as potential therapeutic agents targeting various neurodegenerative diseases." This invention addresses compositions and methods for treating diseases such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, Huntington's disease, and more. The invention also explores methods of fermentation of bacterial cells and tautomerization of these compounds, showcasing innovative approaches to complex medical challenges.

His second patent, "Albofungin and its derivatives specifically recognize HIV-1 LTR-III G-quadruplex," reveals innovative compositions comprising albofungin and its derivatives, including chloroalbofungin and multiple other variants. This patent outlines methods for treating subjects with HIV using these derivatives, reflecting Cheng's commitment to addressing critical health issues.

Career Highlights

Cheng has worked with esteemed institutions, including The Hong Kong University of Science and Technology and the Southern Marine Science and Engineering Guangdong Laboratory. His collaborations have positioned him as a valuable contributor to innovation in the life sciences sector, where his research is paving the way for future therapeutic advancements.

Collaborations

Throughout his career, Aifang Cheng has collaborated with other talented individuals, including Changdong Liu and Wenkang Ye. These partnerships have facilitated a dynamic exchange of ideas and research, fostering an environment conducive to groundbreaking developments in medical treatments.

Conclusion

Aifang Cheng's dedication to innovation and his impressive patent portfolio illustrate his significant role in the fight against neurodegenerative diseases and HIV. His work not only advances scientific understanding but also holds the potential for transformative impacts on public health. As he continues to develop new therapeutics, the future looks promising for both his research and the communities that stand to benefit from it.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…